Miglitol, an Anti-diabetic Drug, Inhibits Oxidative Stress–Induced Apoptosis and Mitochondrial ROS Over-Production in Endothelial Cells by Enhancement of AMP-Activated Protein Kinase
Endothelial dysfunction caused by oxidative stress plays a key role in atherogenesis. This study investigated whether the anti-diabetic drug miglitol, an α-glucosidase inhibitor, which is currently available in clinical practice, can prevent endothelial cell apoptosis and whether it might restore im...
Main Authors: | Chie Aoki, Kunihiro Suzuki, Kazunori Yanagi, Hiroko Satoh, Mai Niitani, Yoshimasa Aso |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319304505 |
Similar Items
-
The effects of miglitol on the pharmacokinetics of phenytoin in healthy volunteers
by: Richardt, Denise
Published: (2018) -
Determination of miglitol with Electrogenerated chemiluminescence detector and it’s application on HPLC
by: Ping-Hong Wu, et al.
Published: (2015) -
Development and Validation of Miglitol and Its Impurities by RP-HPLC and Characterization Using Mass Spectrometry Techniques
by: Kesavan Balakumaran, et al.
Published: (2016-10-01) -
Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus
by: Nomura S, et al.
Published: (2011-07-01) -
HSP27 Inhibits Homocysteine-Induced Endothelial Apoptosis by Modulation of ROS Production and Mitochondrial Caspase-Dependent Apoptotic Pathway
by: Xin Tian, et al.
Published: (2016-01-01)